Relevium Issues Important Clarification About Bioganix CleanCare Brand

Relevium Issues Important Clarification About Bioganix CleanCare Brand

MONTREAL, June 23, 2020 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an important clarification about Bioganix CleanCare, its brand of disinfection and wellness products.
On. June 19, 2020, the FDA issued a public health warning about nine (9) hand sanitizers manufactured by Eskbiochem SA, four (4) “CleanCare No Germ Advanced” branded products that could contain potentially dangerous chemicals.This FDA warning about Eskbiochem SA is 100% UNRELATED to BIOGANIX CLEANCARE.Relevium and its executive team would like to provide comfort to its customers and shareholders that there is ZERO relation between Bioganix CleanCare, the nine products recalled and its manufacturer, who uses a similar name for some of its products.Our Bioganix CleanCare disinfection products are manufactured at our partner contract manufacturers located in the US and Canada. Bioganix only contracts FDA and Health Canada approved facilities, following good manufacturing practices and the Bioganix CleanCare disinfection products are formulated using only accepted medical grade ingredients that meet or exceeded national and international standards.Aurelio Useche CEO of Relevium stated: “We are very pleased to be able to distance ourselves from any product and manufacturer that does not meet top tier status for quality and safety track record. Our investors and customers alike can rest assured that our products meet the highest level of quality in terms of ingredients, manufacturing process and formulation”Aurelio Useche stated further: “There is ZERO link between Bioganix CleanCare and ANY other CleanCare branded product in the market. There is only ONE Bioganix CleanCare and we stand behind our brand and its tradition for excellence”Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
                                                                                              
About Relevium Technologies
Relevium is a publicly traded Company that operates in the health and wellness industry, including legal cannabis, with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operation of brands and businesses in the health and wellness markets and medical cannabis. The Company pursues its business strategy through an acquisition and partnership model in a holistic approach to encompass a wide range of health and wellness consumer products. Relevium operates through two wholly owned subsidiaries:BGX E-Health LLC (BGX), based in Orlando, Florida, markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals primarily through its Bioganix® brand portfolio in the US and Europe.Relevium’s premium brands are sold at some of the world’s largest retailers including Walmart.com and Amazon.com.Biocannabix Health Corporation (BCX), based in Montreal, Quebec, is a biopharma nutraceutical Company focused on delivering pediatric endo-medicinal nutraceuticals for cannabinoid therapy.Cautionary Note Regarding Forward-Looking Statements
CBJ Newsmakers

Recommended
Globex Mining Enterprises Announces Results of Annual MeetingOsisko Infill Drilling Continues to Confirm High Grade at Lynx